Can medroxyprogesterone acetate alter Toll-like receptor expression in a mouse model of intrauterine inflammation?
- 1 September 2005
- journal article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 193 (3) , 1149-1155
- https://doi.org/10.1016/j.ajog.2005.05.043
Abstract
No abstract availableKeywords
Funding Information
- Bill and Melinda Gates Foundation
- University of Pennsylvania
This publication has 26 references indexed in Scilit:
- Antibiotics for treating bacterial vaginosis in pregnancyPublished by Wiley ,2005
- Induction of Nuclear Factor–κB and c‐Jun/Activator Protein–1 via Toll‐Like Receptor 2 in Macrophages by Antimycotic‐TreatedCandida albicansThe Journal of Infectious Diseases, 2004
- Toll‐like receptor (TLR) expression and TLR‐mediated cytokine/chemokine production by human uterine epithelial cellsImmunology, 2004
- Regulation of the lipopolysaccharide signal transduction pathway by 17β-estradiol in macrophage cellsThe Journal of Steroid Biochemistry and Molecular Biology, 2004
- Medroxyprogesterone acetate, but not progesterone, protects against inflammation-induced parturition and intrauterine fetal demiseAmerican Journal of Obstetrics and Gynecology, 2004
- Cooperation between toll‐like receptor 2 and 4 in the brain of mice challenged with cell wall components derived from gram‐negative and gram‐positive bacteriaEuropean Journal of Immunology, 2003
- Regulatory T Cells Selectively Express Toll-like Receptors and Are Activated by LipopolysaccharideThe Journal of Experimental Medicine, 2003
- Novel Signal Transduction Pathway Utilized by Extracellular HSP70Journal of Biological Chemistry, 2002
- The Extra Domain A of Fibronectin Activates Toll-like Receptor 4Journal of Biological Chemistry, 2001
- Host Defense Mechanisms Triggered by Microbial Lipoproteins Through Toll-Like ReceptorsScience, 1999